Business Description
PW Medtech Group Ltd
ISIN : KYG7306W1087
Compare
Compare
Traded in other countries / regions
01358.Hong KongPWE.Germany IPO Date
2013-11-08Description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. It generates maximum revenue from Blood Purification Business. Geographically, it operates in China, North America, India and Others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1413.37 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 1052.45 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 4.01 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36.2 | |||||
| 3-Year EBITDA Growth Rate | -23 | |||||
| 3-Year EPS without NRI Growth Rate | -12.6 | |||||
| 3-Year FCF Growth Rate | 19.3 | |||||
| 3-Year Book Growth Rate | -9.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.13 | |||||
| 9-Day RSI | 74.22 | |||||
| 14-Day RSI | 70.27 | |||||
| 6-1 Month Momentum % | 24.68 | |||||
| 12-1 Month Momentum % | 81.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.61 | |||||
| Quick Ratio | 12.7 | |||||
| Cash Ratio | 10.68 | |||||
| Days Inventory | 172.38 | |||||
| Days Sales Outstanding | 41.15 | |||||
| Days Payable | 42.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.76 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| Forward Dividend Yield % | 9.56 | |||||
| 5-Year Yield-on-Cost % | 4.76 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 7.21 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.42 | |||||
| Operating Margin % | 24.09 | |||||
| Net Margin % | 22.69 | |||||
| FCF Margin % | 19.13 | |||||
| ROE % | 3.81 | |||||
| ROA % | 3 | |||||
| ROIC % | 4.11 | |||||
| ROC (Joel Greenblatt) % | 22.06 | |||||
| ROCE % | 4.68 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.63 | |||||
| PE Ratio without NRI | 9.63 | |||||
| Shiller PE Ratio | 3.22 | |||||
| Price-to-Owner-Earnings | 7.63 | |||||
| PEG Ratio | 0.6 | |||||
| PS Ratio | 2.16 | |||||
| PB Ratio | 0.36 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| Price-to-Free-Cash-Flow | 11.33 | |||||
| Price-to-Operating-Cash-Flow | 6.89 | |||||
| EV-to-EBIT | -0.44 | |||||
| EV-to-EBITDA | -0.44 | |||||
| EV-to-Revenue | -0.15 | |||||
| EV-to-FCF | -0.79 | |||||
| Price-to-Projected-FCF | 0.36 | |||||
| Price-to-Median-PS-Value | 0.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.58 | |||||
| Price-to-Graham-Number | 0.52 | |||||
| Price-to-Net-Current-Asset-Value | 1.58 | |||||
| Price-to-Net-Cash | 3.03 | |||||
| Earnings Yield (Greenblatt) % | -227.27 | |||||
| FCF Yield % | 8.76 | |||||
| Forward Rate of Return (Yacktman) % | 21.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PW Medtech Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 738.393 | ||
| EPS (TTM) (HK$) | 0.107 | ||
| Beta | 0.12 | ||
| Volatility % | 44.14 | ||
| 14-Day RSI | 70.27 | ||
| 14-Day ATR (HK$) | 0.028629 | ||
| 20-Day SMA (HK$) | 0.971 | ||
| 12-1 Month Momentum % | 81.13 | ||
| 52-Week Range (HK$) | 0.485 - 1.04 | ||
| Shares Outstanding (Mil) | 1,565.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PW Medtech Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PW Medtech Group Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PW Medtech Group Ltd Frequently Asked Questions
What is PW Medtech Group Ltd(HKSE:01358)'s stock price today?
The current price of HKSE:01358 is HK$1.03. The 52 week high of HKSE:01358 is HK$1.04 and 52 week low is HK$0.49.
When is next earnings date of PW Medtech Group Ltd(HKSE:01358)?
The next earnings date of PW Medtech Group Ltd(HKSE:01358) is .
Does PW Medtech Group Ltd(HKSE:01358) pay dividends? If so, how much?
The Dividend Yield %  of PW Medtech Group Ltd(HKSE:01358) is 4.76% (As of Today), Highest Dividend Payout Ratio of PW Medtech Group Ltd(HKSE:01358) was 0.47. The lowest was 0.46. And the median was 0.46. The  Forward Dividend Yield % of PW Medtech Group Ltd(HKSE:01358) is 9.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers